Format
Sort by
Items per page

Send to

Choose Destination

UI-R-C1-ln-d-02-0-UI.s1 UI-R-C1 Rattus norvegicus cDNA clone UI-R-C1-ln-d-02-0-UI 3', mRNA sequence [Rattus norvegicus]

Search results

Items: 1 to 20 of 170

1.

Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights.

Buchanan AL, Hudgens MG, Cole SR, Mollan KR, Sax PE, Daar ES, Adimora AA, Eron JJ, Mugavero MJ.

J R Stat Soc Ser A Stat Soc. 2018 Oct;181(4):1193-1209. doi: 10.1111/rssa.12357. Epub 2018 Feb 26.

PMID:
30555215
2.

Non-Hodgkin lymphoma risk in adults living with HIV across five continents.

AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord.

AIDS. 2018 Nov 28;32(18):2777-2786. doi: 10.1097/QAD.0000000000002003.

3.

Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis.

Grover S, Desir F, Jing Y, Bhatia RK, Trifiletti DM, Swisher-McClure S, Kobie J, Moore RD, Rabkin CS, Silverberg MJ, Salters K, Mathews WC, Gill MJ, Thorne JE, Castilho J, Kitahata MM, Justice A, Horberg MA, Achenbach CJ, Mayor AM, Althoff KN; North American AIDS Cohort Collaboration on Research and Design.

J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):421-429. doi: 10.1097/QAI.0000000000001842.

PMID:
30211722
4.

Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy.

Lee JS, Cole SR, Achenbach CJ, Dittmer DP, Richardson DB, Miller WC, Mathews C, Althoff KN, Moore RD, Eron JJ Jr; Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS).

PLoS One. 2018 Jun 5;13(6):e0197665. doi: 10.1371/journal.pone.0197665. eCollection 2018.

5.

Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada.

Yanik EL, Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Horberg MA, Moore RD, Mathews WC, Justice AC, Hessol NA, Mayor AM, Gill MJ, Brooks JT, Sun J, Althoff KN, Engels EA, Silverberg MJ, Dubrow R.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):499-504. doi: 10.1097/QAI.0000000000001719.

PMID:
29771785
6.

HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.

Tymejczyk O, Brazier E, Yiannoutsos C, Wools-Kaloustian K, Althoff K, Crabtree-Ramírez B, Van Nguyen K, Zaniewski E, Dabis F, Sinayobye JD, Anderegg N, Ford N, Wikramanayake R, Nash D; IeDEA Collaboration.

PLoS Med. 2018 Mar 23;15(3):e1002534. doi: 10.1371/journal.pmed.1002534. eCollection 2018 Mar.

7.

Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunities.

Lesko CR, Jacobson LP, Althoff KN, Abraham AG, Gange SJ, Moore RD, Modur S, Lau B.

Int J Epidemiol. 2018 Apr 1;47(2):654-668. doi: 10.1093/ije/dyx283.

PMID:
29438495
8.

Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015.

Bengtson AM, Pence BW, Eaton EF, Edwards JK, Eron JJ, Mathews WC, Mollan K, Moore RD, O'Cleirigh C, Geng E, Mugavero MJ.

Antivir Ther. 2018;23(4):363-372. doi: 10.3851/IMP3223.

9.

Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV.

Elion RA, Althoff KN, Zhang J, Moore RD, Gange SJ, Kitahata MM, Crane HM, Drozd DR, Stein JH, Klein MB, Eron JJ, Silverberg MJ, Mathews WC, Justice AC, Sterling TR, Rabkin CS, Mayor AM, Klein DB, Horberg MA, Bosch RJ, Eyawo O, Palella FJ Jr; North American AIDS Cohort Collaboration on Research and Design of IeDEA.

J Acquir Immune Defic Syndr. 2018 May 1;78(1):62-72. doi: 10.1097/QAI.0000000000001642.

PMID:
29419568
10.

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs.

IeDEA and COHERE Cohort Collaborations .

Clin Infect Dis. 2018 Mar 5;66(6):893-903. doi: 10.1093/cid/cix915.

11.

Cancer burden attributable to cigarette smoking among HIV-infected people in North America.

Altekruse SF, Shiels MS, Modur SP, Land SR, Crothers KA, Kitahata MM, Thorne JE, Mathews WC, Fernández-Santos DM, Mayor AM, Gill JM, Horberg MA, Brooks JT, Moore RD, Silverberg MJ, Althoff KN, Engels EA.

AIDS. 2018 Feb 20;32(4):513-521. doi: 10.1097/QAD.0000000000001721.

PMID:
29239891
12.

Considerations for analysis of time-to-event outcomes measured with error: Bias and correction with SIMEX.

Oh EJ, Shepherd BE, Lumley T, Shaw PA.

Stat Med. 2018 Apr 15;37(8):1276-1289. doi: 10.1002/sim.7554. Epub 2017 Nov 29.

PMID:
29193180
13.

Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected.

Eyawo O, McGinnis KA, Justice AC, Fiellin DA, Hahn JA, Williams EC, Gordon AJ, Marshall BDL, Kraemer KL, Crystal S, Gaither JR, Edelman EJ, Bryant KJ, Tate JP; VACS Project team.

J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):135-143. doi: 10.1097/QAI.0000000000001588.

14.

Marijuana use and HIV treatment outcomes among PWH receiving care at an urban HIV clinic.

Sinha S, McCaul ME, Hutton HE, Monroe AK, Alvanzo A, Lesko C, Lau B, Keruly J, Moore RD, Chander G.

J Subst Abuse Treat. 2017 Nov;82:102-106. doi: 10.1016/j.jsat.2017.09.009. Epub 2017 Sep 15.

15.

Gonorrhea and Chlamydia Case Detection Increased When Testing Increased in a Multisite US HIV Cohort, 2004-2014.

Raifman JR, Gebo KA, Mathews WC, Korthuis PT, Ghanem KG, Aberg JA, Moore RD, Nijhawan AE, Monroe AK, Berry SA; HIV Research Network.

J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):409-416. doi: 10.1097/QAI.0000000000001514.

16.

HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration.

Jiamsakul A, Kariminia A, Althoff KN, Cesar C, Cortes CP, Davies MA, Do VC, Eley B, Gill J, Kumarasamy N, Machado DM, Moore R, Prozesky H, Zaniewski E, Law M.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):319-329. doi: 10.1097/QAI.0000000000001499.

17.

High hepatitis C cure rates among black and nonblack human immunodeficiency virus-infected adults in an urban center.

Falade-Nwulia O, Sutcliffe C, Moon J, Chander G, Wansom T, Keruly J, Katzianer J, Nathanson A, Marks J, Mehta S, Thomas D, Moore R, Sulkowski M.

Hepatology. 2017 Nov;66(5):1402-1412. doi: 10.1002/hep.29308. Epub 2017 Oct 11.

18.

New Faces of HIV Infection: Age, Race, and Timing of Entry into HIV Care in the Southeastern United States.

Rebeiro PF, Ivey KS, Craig KS, Hulgan T, Huaman MA, Nash R, Raffanti S, Equakun KA, Person AK.

J Int Assoc Provid AIDS Care. 2017 Jul/Aug;16(4):347-352. doi: 10.1177/2325957417710719. Epub 2017 May 31.

19.

Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population.

Drozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, Burkholder GA, Mathews WC, Silverberg MJ, Sterling TR, Heckbert SR, Budoff MJ, Van Rompaey S, Delaney JAC, Wong C, Tong W, Palella FJ, Elion RA, Martin JN, Brooks JT, Jacobson LP, Eron JJ, Justice AC, Freiberg MS, Klein DB, Post WS, Saag MS, Moore RD, Crane HM.

J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):568-576. doi: 10.1097/QAI.0000000000001450.

20.

Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors.

Muzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB, Kitahata MM, Horberg MA, Justice AC, Fischer MJ, Silverberg MJ, Butt AA, Boswell SL, Rachlis AR, Mayor AM, Gill MJ, Eron JJ, Napravnik S, Drozd DR, Martin JN, Bosch RJ, Durand CM, Locke JE, Moore RD, Lucas GM, Segev DL.

Am J Transplant. 2017 Jul;17(7):1823-1832. doi: 10.1111/ajt.14235. Epub 2017 May 12.

Supplemental Content

Loading ...
Support Center